Telix Pharmaceuticals Ltd (TLX) stock
TLXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as TLPPF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Feb 20, 2026Score 3/30
$8.71−0.25 (-2.79%)
Close on Nov 19, 2026Market cap $2.95BP/E –Yield –
Telix Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was $803.79M, up 55.6% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $803.79M | +55.6% |
| FY2024 | Dec 31, 2024 | $516.55M | +55.1% |
| FY2023 | Dec 31, 2023 | $332.98M | – |
See a number that looks wrong?